StonvexLoading…
StonvexStonvexStonvexCore line items from SABS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $1.32M | $2.24M | $23.90M |
Operating Income | $-48.95M | $-42.91M | $-38.08M | $-28.92M |
Net Income | $13.27M | $-34.11M | $-42.19M | $-18.74M |
EPS (Diluted) | $-0.79 | $-3.68 | $-7.64 | $-4.31 |
Total Assets | $172.81M | $44.20M | $83.94M | $50.90M |
Total Liabilities | $21.32M | $18.23M | $26.64M | $19.85M |
Cash & Equivalents | $10.50M | $8.90M | $56.57M | $15.05M |
Free Cash Flow OCF − CapEx | $-45.71M | $-34.63M | $-25.32M | $-25.63M |
Shares Outstanding | 47.61M | 9.29M | 9.23M | 5.04M |